Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.930
+0.150 (8.43%)
At close: Feb 6, 2026, 4:00 PM EST
1.801
-0.129 (-6.69%)
After-hours: Feb 6, 2026, 4:43 PM EST
CELZ Market Cap
CELZ has a market cap or net worth of $6.72 million as of February 6, 2026. Its market cap has increased by 56.34% in one year.
Market Cap
6.72M
Enterprise Value
1.31M
1-Year Change
56.34%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $6.72M, a decrease of -58.24%. That is a compound annual growth rate of -18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 4.60M | -9.80% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 7.11M |
| PharmaCyte Biotech | 7.09M |
| Revelation Biosciences | 6.98M |
| VivoSim Labs | 6.75M |
| Quoin Pharmaceuticals | 6.56M |
| Calidi Biotherapeutics | 6.16M |
| Aptorum Group | 6.03M |
| Aptevo Therapeutics | 6.00M |